MyxoBiomedical
PrivateTotal Funding Raised
$1M
Company Overview
MyxoBiomedical is a biotechnology company that develops resistance-breaking macrolide antibiotics based on the myxobacterial natural product scaffold chlorotonil for the treatment of MRSA and VRE infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MyxoBiomedical Comparables
Compare MyxoBiomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| smartbax GmbH | 88% | |
| Macrolide Pharmaceuticals | 87% | |
| APY Therapeutics | 85% |
MyxoBiomedical Funding Rounds
Historical fundraising activity
MyxoBiomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
MyxoBiomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MyxoBiomedical's valuation, stock price, and market status.
Is MyxoBiomedical a public or private company?
MyxoBiomedical is a private company.
What is the current stock price of MyxoBiomedical?
MyxoBiomedical is a private company with no public stock price. Caplight tracks MyxoBiomedical's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is MyxoBiomedical worth (valuation)?
Valuation information for MyxoBiomedical is not publicly available.
Can I buy MyxoBiomedical stock?
MyxoBiomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MyxoBiomedical's last funding round?
Funding round information for MyxoBiomedical is not publicly available.
Who are the main investors in MyxoBiomedical?
Key investors in MyxoBiomedical include National Cancer Institute.
Will MyxoBiomedical IPO soon?
No public IPO plans have been announced for MyxoBiomedical.
How can I track MyxoBiomedical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MyxoBiomedical's secondary market activity and sign up for updates.